QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Welcome Ville!
We are excited to welcome Ville Perälä, who is joining Quantify Research this week as Country Manager in Finland.
Ville has been working in pharmaceutical business, both as a consultant and in pharma companies, for almost a decade. He has experience from multiple areas, primarily focused on Medical Affairs, Real World Evidence and Market Access strategies in Nordic and Global positions.
“I am super happy […]
Are you or any of your colleagues attending EASL in Milan this week? Quantify is on site and happy to connect!
Two Quantify abstracts have been selected for poster presentation and for oral presentation in the Abstract session – “MASLD: Clinical aspects”.
The presentations include the first results from the REVEAL-MASH study conducted by Quantify’s Emilie Toresson Grip and Helena Skröder Löveborn in ongoing collaboration with Karolinska Institutet and Novo Nordisk. Emilie Toresson Grip will present the findings at […]
Meet our colleagues!
First out is Zoltán Németh, Senior Research Analyst in the Modelling, Access and Strategy unit. Zoltán joined Quantify Research Stockholm at the end of last summer and quickly became an integral part of the team.
𝘡𝘰𝘭𝘵á𝘯, 𝘸𝘩𝘺 𝘥𝘪𝘥 𝘺𝘰𝘶 𝘤𝘩𝘰𝘰𝘴𝘦 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘘𝘶𝘢𝘯𝘵𝘪𝘧𝘺?
Quantify offered an environment that is professional and welcoming, making it an ideal place for professional development.
Additionally, I love modelling and data […]
Interested in how the Quantify team can help in meeting post-authorization commitments through Nordic RWE?
The Quantify Research team has years of experience of designing, supporting, and managing post-authorization studies, and has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centres of Pharmacoepidemiology and Pharmacovigilance) initiative since 2020.
The Nordic data landscape is uniquely suited for studies on drug utilization, assessments of risk minimization measures, and long-term safety, due to several key factors:
𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐜𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐚𝐧𝐝 […]